Serial Number | 86981869 |
Word Mark | REMARKABLE SCIENCE CHANGES EVERYTHING |
Filing Date | Monday, February 22, 2016 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, January 5, 2024 |
Registration Number | 5229229 |
Registration Date | Tuesday, June 20, 2017 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 12, 2016 |
Goods and Services | Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials; Medical and scientific research related to therapeutic and aesthetic applications of neurotoxins; Measurement evaluations in the field of facial wrinkles and lateral canthal lines; Research and development of drug delivery methods and devices; Conducting and evaluating medical and scientific research and clinical trials in the fields of dermatology |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, January 5, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Saturday, March 5, 2016 |
First Use In Commerce Date | Saturday, March 5, 2016 |
Party Name | Revance Therapeutics, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Newark, CA 94560 |
Party Name | Revance Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Newark, CA 94560 |
Party Name | Revance Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Newark, CA 94560 |
Event Date | Event Description |
Friday, January 5, 2024 | CANCELLED SEC. 8 (6-YR) |
Monday, June 20, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Tuesday, June 20, 2017 | REGISTERED-PRINCIPAL REGISTER |
Thursday, May 18, 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Wednesday, May 17, 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Thursday, May 11, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, May 11, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, May 3, 2017 | ASSIGNED TO LIE |
Wednesday, April 19, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 21, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, March 21, 2017 | NON-FINAL ACTION E-MAILED |
Tuesday, March 21, 2017 | SU - NON-FINAL ACTION - WRITTEN |
Wednesday, March 8, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, February 22, 2017 | USE AMENDMENT FILED |
Wednesday, March 8, 2017 | DIVISIONAL PROCESSING COMPLETE |
Wednesday, February 22, 2017 | DIVISIONAL REQUEST RECEIVED |
Wednesday, March 8, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, February 22, 2017 | TEAS REQUEST TO DIVIDE RECEIVED |
Wednesday, February 22, 2017 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, September 6, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 12, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 12, 2016 | PUBLISHED FOR OPPOSITION |
Wednesday, June 22, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, June 8, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, June 7, 2016 | ASSIGNED TO EXAMINER |
Friday, February 26, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, February 25, 2016 | NEW APPLICATION ENTERED |